Safety Advantage: Semaglutide The risk of serious side effects from GLP-1 receptor agonists is relatively low, but common side effects like nausea, indigestion, and other forms of GI upset can be expected by most users.6 These digestive issues tend to fade as your body adjusts to the medication and you make lifestyle adjustments based on how the medication affects your metabolism
and menstrual irregularities in women, as reproductive hormones are sensitive to energy availability
Stomach problems, sometimes severe, have been reported in people who use Wegovy
*Price includes medication only, if prescribed
In the trial, 152 participants with an average BMI of over 38 well above the threshold for obesity got a weekly dose of semaglutide, which is injected under the skin somewhere with fat deposits, such as the stomach area or thigh and 152 others got a weekly placebo injection